Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Vasodilators are medicines that dilate (widen) blood vessels, allowing blood to flow more easily through. Some act directly on the smooth muscle cells lining the blood vessels. Other have a central effect, and regulate blood pressure most likely through the vasomotor center located within the medulla oblongata of the brain.
The overall lifestyle of the global people is changing, which can be reflected by the increasing prevalence of cardiovascular disease. Antiarrhythmic vasodilators are one of the most in-demand drugs among middle-aged and elderly people in the world.
The increasing cardiovascular problems, stress and high blood pressure are the main factors driving the vasodilator market. The ongoing research in the healthcare industry has brought considerable innovation in the field of antiarrhythmic vasodilators, creating new opportunities in this market.
The report details the trend, potential and market size of Vasodilators market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Vasodilatorsmarket, defines the market attractiveness level of Vasodilators market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Vasodilators industry, describes the types of Vasodilators market, the applications of major players and the market size, and deeply analyzes the current situation of the global Vasodilators market and the development prospects and opportunities of Vasodilators industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Vasodilators market in Chapter 13.
By Player:
Novartis
Bristol-Myers Squibb
Eli Lilly
Jhonson and Johnson
Bayer
Pfizer
Sanofi
Astra Zeneca
Teva Pharmaceutical
GSK
Merck
By Type:
Arterial Dilators
Venous Dilators
Mixed Dilators
By End-User:
Hypertension
Angina
Heart Failure
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Vasodilators Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Vasodilators Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Vasodilators Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Vasodilators Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Vasodilators Market Analysis and Outlook to 2022
-
7.1 Global Vasodilators Consumption (2017-2022)
-
7.2 United States Vasodilators Consumption (2017-2022)
-
7.3 Europe Vasodilators Consumption (2017-2022)
-
7.4 China Vasodilators Consumption (2017-2022)
-
7.5 Japan Vasodilators Consumption (2017-2022)
-
7.6 India Vasodilators Consumption (2017-2022)
-
7.7 South Korea Vasodilators Consumption (2017-2022)
8 Region and Country-wise Vasodilators Market Analysis and Outlook to 2028
-
8.1 Global Vasodilators Consumption Forecast (2022-2028)
-
8.2 United States Vasodilators Consumption Forecast (2022-2028)
-
8.3 Europe Vasodilators Consumption Forecast (2022-2028)
-
8.4 China Vasodilators Consumption Forecast (2022-2028)
-
8.5 Japan Vasodilators Consumption Forecast (2022-2028)
-
8.6 India Vasodilators Consumption Forecast (2022-2028)
-
8.7 South Korea Vasodilators Consumption Forecast (2022-2028)
9 Global Vasodilators Market Outlook by Types and Applications to 2022
-
9.1 Global Vasodilators Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Arterial Dilators Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Venous Dilators Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Mixed Dilators Consumption and Growth Rate (2017-2022)
-
9.2 Global Vasodilators Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hypertension Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Angina Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Heart Failure Consumption and Growth Rate (2017-2022)
10 Global Vasodilators Market Outlook by Types and Applications to 2028
-
10.1 Global Vasodilators Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Arterial Dilators Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Venous Dilators Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Mixed Dilators Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Vasodilators Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hypertension Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Angina Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Heart Failure Consumption Forecast and Growth Rate (2022-2028)
11 Global Vasodilators Import and Export Analysis (Top 5 Countries)
-
11.1 Global Vasodilators Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Vasodilators Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Vasodilators Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Vasodilators Market Competitive Analysis
-
14.1 Novartis
-
14.1.1 Novartis Company Details
-
14.1.2 Novartis Vasodilators Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis Vasodilators Product and Service
-
14.2 Bristol-Myers Squibb
-
14.2.1 Bristol-Myers Squibb Company Details
-
14.2.2 Bristol-Myers Squibb Vasodilators Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bristol-Myers Squibb Vasodilators Product and Service
-
14.3 Eli Lilly
-
14.3.1 Eli Lilly Company Details
-
14.3.2 Eli Lilly Vasodilators Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Eli Lilly Vasodilators Product and Service
-
14.4 Jhonson and Johnson
-
14.4.1 Jhonson and Johnson Company Details
-
14.4.2 Jhonson and Johnson Vasodilators Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Jhonson and Johnson Vasodilators Product and Service
-
14.5 Bayer
-
14.5.1 Bayer Company Details
-
14.5.2 Bayer Vasodilators Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bayer Vasodilators Product and Service
-
14.6 Pfizer
-
14.6.1 Pfizer Company Details
-
14.6.2 Pfizer Vasodilators Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Pfizer Vasodilators Product and Service
-
14.7 Sanofi
-
14.7.1 Sanofi Company Details
-
14.7.2 Sanofi Vasodilators Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Sanofi Vasodilators Product and Service
-
14.8 Astra Zeneca
-
14.8.1 Astra Zeneca Company Details
-
14.8.2 Astra Zeneca Vasodilators Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Astra Zeneca Vasodilators Product and Service
-
14.9 Teva Pharmaceutical
-
14.9.1 Teva Pharmaceutical Company Details
-
14.9.2 Teva Pharmaceutical Vasodilators Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Teva Pharmaceutical Vasodilators Product and Service
-
14.10 GSK
-
14.10.1 GSK Company Details
-
14.10.2 GSK Vasodilators Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 GSK Vasodilators Product and Service
-
14.11 Merck
-
14.11.1 Merck Company Details
-
14.11.2 Merck Vasodilators Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Merck Vasodilators Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Vasodilators
-
Figure Vasodilators Picture
-
Table Global Vasodilators Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Vasodilators Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Vasodilators Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Vasodilators Consumption by Country (2017-2022)
-
Figure United States Vasodilators Consumption and Growth Rate (2017-2022)
-
Table Europe Vasodilators Consumption and Growth Rate (2017-2022)
-
Figure China Vasodilators Consumption and Growth Rate (2017-2022)
-
Figure Japan Vasodilators Consumption and Growth Rate (2017-2022)
-
Figure India Vasodilators Consumption and Growth Rate (2017-2022)
-
Figure South Korea Vasodilators Consumption and Growth Rate (2017-2022)
-
Figure Global Vasodilators Consumption Forecast by Country (2022-2028)
-
Figure United States Vasodilators Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Vasodilators Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Vasodilators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Vasodilators Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Vasodilators Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Vasodilators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Arterial Dilators Consumption and Growth Rate (2017-2022)
-
Figure Global Venous Dilators Consumption and Growth Rate (2017-2022)
-
Figure Global Mixed Dilators Consumption and Growth Rate (2017-2022)
-
Figure Global Hypertension Consumption and Growth Rate (2017-2022)
-
Figure Global Angina Consumption and Growth Rate (2017-2022)
-
Figure Global Heart Failure Consumption and Growth Rate (2017-2022)
-
Figure Global Arterial Dilators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Venous Dilators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mixed Dilators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hypertension Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Angina Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Heart Failure Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Vasodilators Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Vasodilators Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Vasodilators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Vasodilators Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Vasodilators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Vasodilators Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Vasodilators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Vasodilators Product and Service
-
Table Jhonson and Johnson (Foundation Year, Company Profile and etc.)
-
Table Jhonson and Johnson Vasodilators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jhonson and Johnson Vasodilators Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Vasodilators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Vasodilators Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Vasodilators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Vasodilators Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Vasodilators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Vasodilators Product and Service
-
Table Astra Zeneca (Foundation Year, Company Profile and etc.)
-
Table Astra Zeneca Vasodilators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astra Zeneca Vasodilators Product and Service
-
Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Vasodilators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Vasodilators Product and Service
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK Vasodilators Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Vasodilators Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Vasodilators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Vasodilators Product and Service
-
